Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention
Change of Adipose Tissues and Triglyceride in Obese Patients With Non-alcoholic Fatty Liver Disease After Bariatric Surgery or Life-style Intervention
Chinese University of Hong Kong
80 participants
Apr 1, 2019
INTERVENTIONAL
Conditions
Summary
The study is aimed * To quantify the change of adipose tissues, triglyceride in liver and pancreas and cholesterol after lifestyle intervention or bariatric surgery. * To test the hypothesis that Brown fat is an independent biomarker for the development of Non Alcoholic Fat Liver Disease (NAFLD) * To study the association among Brown fat, NAFLD and obesity.
Eligibility
Inclusion Criteria3
- BMI ≥ 25-30 kg/m2
- BMI ≥ 30 kg/m2 with Metabolic syndrome
- BMI ≥ 35 kg/m2 for morbid obesity
Exclusion Criteria5
- Other kind of hepatic diseases
- Under medications known to affect liver fat
- Waist circumference ≥ 150 cm
- Weight ≥ 250 kg
- MRI contraindications
Interventions
Use of the normal bariatric surgery procedures commonly conducted in our hospital, such as: Laparoscopic Roux-en-Y gastric bypass (RYGB) and Laparoscopic sleeve gastrectomy (LSG)
Intensive 6 months life style changes supervised by diatitians.
receive routine care
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03875625